Evidence map›Paper›PMID 39723341›Full record

ArticleClinical, cosmetic and investigational dermatology2024

The Impact of Immune Cells, Metabolites, Inflammatory Factors, and Circulating Proteins on Atopic Dermatitis: Insights from a Mendelian Randomization Study.

Dongqi Zhou, Gaofeng Gan, Shiwei Song, Cangyan Zi, Yichen Bao, Wenfeng Hao, Qiu Chen

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dongqi ZhouSichuan Taikang Hospital, Chengdu, Sichuan Province, 610213, People's Republic of China.
Gaofeng GanSichuan Taikang Hospital, Chengdu, Sichuan Province, 610213, People's Republic of China.
Shiwei SongSichuan Taikang Hospital, Chengdu, Sichuan Province, 610213, People's Republic of China.
Cangyan ZiSichuan Taikang Hospital, Chengdu, Sichuan Province, 610213, People's Republic of China.
Yichen BaoSichuan Taikang Hospital, Chengdu, Sichuan Province, 610213, People's Republic of China.
Wenfeng HaoSichuan Taikang Hospital, Chengdu, Sichuan Province, 610213, People's Republic of China.
Qiu ChenHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, 610072, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The onset of atopic dermatitis (AD) is complex, and its specific pathological mechanisms have not yet been fully elucidated. Methods: Using circulating multi-omics as the exposure factors and AD as the outcome, we conducted univariable MR analysis. The circulating multi-omics data included immunomics (731 immune cell types), proteomics (4907 plasma proteins), metabolomics (1400 metabolites and 486 additional metabolites), and 91 inflammatory factors. MR analysis was conducted using IVW, WM, Simple Mode, Weighted Mode, and MR-Egger methods, with IVW as the primary analysis tool. To address horizontal pleiotropy, we utilized MR-Egger intercept tests and MR-PRESSO for correction, alongside the Cochrane Q statistic for heterogeneity assessment. Sensitivity analysis was performed using a leave-one-out strategy. To control for false positives due to multiple testing, we set a standard of a 5% false discovery rate. Additionally, we conducted F-statistics on the included SNPs to eliminate the impact of weak instrumental variables. Results: IL-18R1 on AD (OR = 1.12, 95% CI: 1.08-1.17, Conclusion: This study further explored the correlations between multi-omics data and AD. We identified seven previously unreported circulating substances with causal relationships to AD, filling a current theoretical gap.

Indexed as

atopic dermatitisimmunomicsMendelian randomizationmetabolomicsmulti-omicsproteomics

Identifiers

PMID39723341
PMCPMC11669345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.